Evidence map›Paper›PMID 40229239›Full record

ArticleBlood cancer journal2025

Cardiovascular adverse events and outcomes after anti-BCMA CAR-T for relapsed and refractory multiple myeloma.

Stefanie Palfi, Lauren C Peres, Himara Koelmeyer, Melissa Alsina, Rachid C Baz, Brandon J Blue, Salvatore Corallo, Gabriel De Avila, Ciara Freeman, Rebecca Gonzalez and 16 more

Abstract readLetter
In one paragraph

Article in Blood cancer journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. NAT10-Mediated ac4C Modification of circANKRD12 Reprograms the Tumor Microenvironment.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Stefanie PalfiDivision of Cardiovascular Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
Lauren C PeresDepartment of Cancer Epidemiology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0002-6620-8600
Himara KoelmeyerDivision of Cardiovascular Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
Melissa AlsinaDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Rachid C BazDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Brandon J BlueDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0003-0639-3768
Salvatore CoralloDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Gabriel De AvilaDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Ciara FreemanDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Rebecca GonzalezDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0003-0024-0699
Ariel Grajales-CruzDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Kristy HarveyDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Hien D LiuDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Taiga NishihoriDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0002-2621-7924
Guilherme H OliveiraDivision of Cardiovascular Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
Laura B OswaldDepartment of Health Outcomes and Behavior, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Omar Castaneda PuglianiniDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0003-0423-5870
Sruthi SelvakumarDepartment of Internal Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
Alexis Behne SharmaMorsani College of Medicine, University of South Florida, Tampa, FL, USA.
Elicia WangMorsani College of Medicine, University of South Florida, Tampa, FL, USA.
Kenneth H ShainDepartment of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Michael JainDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.ORCID http://orcid.org/0000-0002-7789-1257
Frederick L LockeDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Mohammed AlomarDivision of Cardiovascular Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
Doris K Hansen *Department of Malignant Hematology, H. Lee Moffitt Cancer Center, Tampa, FL, USA. Doris.hansen@moffitt.org.ORCID http://orcid.org/0000-0002-9813-3578
Dae Hyun Lee *Division of Cardiovascular Medicine, University of South Florida Morsani College of Medicine, Tampa, FL, USA. Daehyunlee@usf.edu.ORCID http://orcid.org/0000-0001-8141-0404

Funding

Survivorship in Patients with Multiple Myeloma Treated with Chimeric Antigen Receptor T-cell TherapyR01CA281756 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI Doris K Hansen, Laura B. Oswald · 2024 to 2026
$3.4M
American Heart Association (American Heart Association, Inc.) 24CDA1271837Florida Department of Health MOABENCI NIH HHS R01 CA281756
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40229239
PMCPMC11997198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.